 This review found that there are significant variations in the quality of COVID-19 treatment guidelines across different countries. Even when guidelines use the same evidence, they can still vary significantly in their recommendations. The authors suggest that these differences may be due to the availability and consistency of clinical data, visibility of trial endpoints, and context-specific factors. This article was authored by David A. Wall, April A. Espinueva, Lauren Dow, and others.